Epidemiology of oral yeast colonization and infection in patients with hematological malignancies, head neck and solid tumors

Journal of Oral Pathology and Medicine

Volumn 40, Issue 1, 2011, Pages 83-89

  Schelenz, Silke ^a   Abdallah, Shaker ^a   Gray, Gill ^a   Stubbings, Helen ^a   Gow, Isobel ^a   Baker, Peter ^a   Hunter, Paul R ^b  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Cancer; Epidemiology; Oral candidiasis

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; NYSTATIN; VORICONAZOLE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; DENTURE; FEMALE; FUNGAL COLONIZATION; FUNGUS CULTURE; FUNGUS IDENTIFICATION; HEAD AND NECK INFECTION; HEAD AND NECK TUMOR; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; INFECTION RISK; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUTH HYGIENE; MYCOSIS; MYELOMA; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SOLID TUMOR; THRUSH; YEAST;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CANDIDA; CANDIDIASIS, ORAL; DENTURES; FEMALE; GREAT BRITAIN; HEAD AND NECK NEOPLASMS; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 78650786586     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2010.00937.x     Document Type: Article

References (42)

1. Jham BC, Franca EC, Oliveira RR, et al. Candida oral colonization and infection in Brazilian patients undergoing head neck radiotherapy: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: 335-58.
2. Jham BC, Reis PM, Miranda EL, et al. Oral health status of 207 head and neck cancer patients before, during and after radiotherapy. Clin Oral Invest 2008; 12: 19-24.
3. Davies A, Brailsford SR, Beighton D. Oral candidosis in patients with advanced cancer. Oral Oncol 2006; 42: 698-702.
4. Davies AN, Brailsford SR, Beighton D, Shorthose K, Stevens VC. Oral candidosis in community based patients with advanced cancer. J Pain Symptom Manage 2008; 35: 508-14.
5. Epstein JB, Hancock PJ, Nantel S. Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis. Oral Surg Med Oral Pathol Oral Radiol Endod 2003; 96: 154-63.
6. Rodu B, Griffin IL, Gockerman JP. Oral candidiasis in cancer patients. South Med J 1984; 77: 312-4.
7. Bergmann OJ. Alteration in oral microflora and pathogenesis of acute oral infections during remission-induction therapy in patients with acute myeloid leukaemia. Sand J Infect Dis 1991; 23: 355-66.
8. Wahlin YB. Salivary secretion rate, yeast cells and oral candidiasis in patients with acute leukemia. Oral Surg Oral Med Oral Pathol 1991; 71: 689-95.
9. Samonis G, Skordilis P, Maraki S, et al. Oropharyngeal candidiasis as a marker for esophageal candidiasis in patients with cancer. Clin Infect Dis 1998; 27: 283-6.
10. DeGregorio MW, Lee WM, Ries C A. Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis. Cancer 1982; 50: 2780-4.
11. Epstein JB, Truelove EL, Izutuzu KL. Oral candidiasis: pathogenesis and host defence. Rev Infect Dis 1984; 6: 96-106.
12. Tapper-Jones TM, Alfred MJ, Walker DM, Hayes TM. Candidal infections and populations of Candida albicans in mouths of diabetics. J Clin Pathol 1981; 24: 706-11.
13. Vogt FC. The incidence of oral candidiasis with use of inhaled corticosteroids. Ann Allergy 1979; 43: 205-10.
14. Bagg J, Sweeney MP, Lewis MAO, et al. High prevalence of non-albicans yeast and detection of anti-fungal resistance in the oral flora of patients with advanced cancer. Palliat Med 2003; 17: 477-81.
15. Redding SW, Dahiya MC, Kirkpatrick WR, et al. Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 97: 47-52.
16. Rautema R, Rusanen P, Richardson M, Meurman JH. Optimal sampling site for mucosal candidosis in oral cancer patients is the labial sulcus. J Med Microbial 2006; 55: 1447-51.
17. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. M27-A2 NCCLS. National Committee for Clinical Laboratory Standards, Wayne, PA, 2002.
18. National Committee for Clinical Laboratory Standards. Method for antifungal disk diffusion susceptibility testing of yeasts; approved guideline. M44-A NCCLS. National Committee for Clinical Laboratory Standards, Wayne, PA, 2004.
19. Pfaller MA, Diekema DJ, Rex JH, et al. Correlation of MIC with outcome for Candida species testing against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol 2006; 44: 819-26.
20. Davies AN, Brailsford S, Broadley K, Beighton D. Resistance amongst yeasts isolated from oral cavities of parents with advanced cancer. Palliat Med 2002; 16: 527-31.
21. Ramirez-Amador V, Silverman S, Mayer P, Tyler M, Quivey J. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. Oral Surg Med Oral Pathol Oral Radiol Endod 1997; 84: 149-53.
22. Rodu B, Carpenter JT, Jones MR. The pathogenesis and clinical significance of cytologically detectable oral Candida in acute leukemia. Cancer 1988; 62: 2042-6.
23. Jobbins J, Bagg J, Parsons K, Finlay I, Addy M, Newcombe RG. Oral carriage of yeasts, coliforms and staphylococci in patients with advanced malignant disease. J Oral Pathol Med 1992; 21: 305-8.
24. Dahiya MC, Redding SW, Dahiya RS, et al. Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-neck cancer. Int J Rad Oncol Biol Phys 2003; 57: 79-83.
25. Redding SW, Zellars RC, Kirkpatrick WR, et al. Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. J Clin Microbiol 1999; 37: 3896-900.
26. Grötz KA, Genitsariotis S, Vehling D, Al-Nawas B. Long-term oral Candida colonization, mucositis and salivary function after head and neck radiotherapy. Support Care Cancer 2003; 11: 717-21.
27. Bergmann OJ, Andersen PL. Acute oral candidiasis during febrile episodes in immunocompromised patients with haematologic malignancies. Scand J Infect Dis 1990; 22: 353-8.
28. Soysa NS, Samaranayake LP, Ellepola ANB. Cytotoxic drugs, radiotherapy and oral candidiasis. Oral Oncol 2004; 40: 971-8.
29. Fanello S, Bouchara JP, Sauteron M, et al. Predictive value of oral colonization by Candida yeasts for the onset of a nosocomial infection in elderly hospitalized patients. J Med Microbiol 2006; 55: 223-8.
30. Butticaz G, Zulian GB, Preumont M, Budtz-Jorgensen E. Evaluation of a nystatin containing mouth rinse for terminally ill patients in palliative care. J Palliat Care 2003; 19: 95-9.
31. Shay K, Truhlar MR, Renner RP. Renner. Oropharyngeal candidosis in the older patient. J Am Geriatr Soc 1997; 15: 7025.
32. Cannon RD, Chaffin WL. Oral colonization by Candida albicans. Crit Rev Oral Biol Med 1999; 10: 359-83.
33. Daniluk T, Tokajuk G, Stokowska W, et al. Occurrence rate of oral Candida albicans in denture wearer patients. Adv Med Sci 2006; 51: 77-80.
34. Chandra J, Mukherjee PK, Leidich SD, et al. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res 2001; 80: 903-8.
35. Clarke JMG, Wilson JA, Haacke NP, Milne LJR. Oral candidiasis in terminal illness. Heath Bull (Edinb) 1987; 45: 268-71.
36. Boggs DR, Williams AF, Howell A. Thrush in malignant neoplastic disease. Arch Intern Med 1961; 107: 354-60.
37. Finlay IG. Oral symptoms and candida in the terminally ill. BMJ 1986; 292: 592-3.
38. Sebti A, Kiehn TE, Perlin D, et al. Candida dubliniensis at a cancer center. Clin Infect Dis 2001; 31: 1034-8.
39. Lefebvre J-L, Domenge C. A comparative study of the efficacy and safety of fluconazole oral suspension and amphotericin B oral suspension in cancer patients with mucositis. Oral Oncol 2002; 38: 337-42.
40. Young GAR, Bosly A, Gibbs DL, Durrant S, and the antifungal prophylaxis study group. A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia. Eur J Cancer 1999; 35: 1208-13.
41. Worthington HVO, Eden B, Clarkson JE. Interventions for preventing oral candidiasis for patients with cancer receiving treatment (review). Cochrane Database Syst Rev 2007; 1: CD003807.
42. van Asbeck EC, Hoepelman AI, Scharringa J, Verhoef J. The echinocandin caspofungin impairs the innate immune mechanism against Candida parapsilosis. Int J Antimicrob Agents 2009; 33: 21-6.